Show Notes
In this episode, we discuss the optimism among Connecticut cannabis dispensaries following news that the federal government might reclassify cannabis as a Schedule III drug. This potential reclassification could significantly benefit the industry by improving access to financial services, reducing tax burdens, and enhancing operational efficiencies. Dispensaries are hopeful that these changes will help alleviate some of the challenges they currently face, making the market more robust and accessible.
Tune in for all the details. Learn more here.
